Youngevity International, Inc. (YGYIP) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Youngevity International, Inc. (YGYIP) trades at $0.20. Youngevity International, Inc. develops and distributes health and nutrition-related products through direct selling, commercial coffee, and commercial hemp segments. Sector: Consumer defensive.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for YGYIP: YGYIP does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates YGYIP against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on YGYIP.
How is this calculated? →Youngevity International, Inc. (YGYIP) Consumer Business Overview
Youngevity International, Inc. operates within the consumer defensive sector, focusing on health and nutrition through direct selling, commercial coffee, and hemp. Its diverse product portfolio and multi-channel distribution strategy aim to capture a broad customer base, though profitability remains a challenge with negative profit margins.
What Is the Investment Thesis for YGYIP?
Youngevity International, Inc. presents a high-risk, high-reward investment profile. The company's diverse product range and multi-channel distribution strategy offer growth potential in the expanding health and wellness market. However, the company's negative profit margin of -35.3% and reliance on the OTC market introduce significant financial and liquidity risks. Key value drivers include the expansion of the Commercial Hemp segment and the growth of its direct selling network. Ongoing catalysts involve potential regulatory changes in the CBD market and the expansion of its coffee distribution network. Investors should carefully consider the high beta of 3.03, indicating significant volatility, and the absence of dividends before investing. The company's ability to achieve profitability and improve its financial stability is crucial for long-term success.
Based on FMP financials and quantitative analysis
YGYIP Key Highlights
Youngevity International, Inc. operates in three segments: Direct Selling, Commercial Coffee, and Commercial Hemp, diversifying its revenue streams.
- The company's gross margin of 63.7% indicates strong pricing power in its product offerings.
- Youngevity markets its products through multiple online platforms, including youngevity.com, hempfx.com, and cafelarica.com, enhancing its direct-to-consumer reach.
- The company's beta of 3.03 suggests high volatility compared to the broader market.
- Youngevity's negative profit margin of -35.3% highlights challenges in achieving profitability.
Who Are YGYIP's Competitors?
YGYIP is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BRCNF Burcon NutraScience Corporation | $1.35 | -2.88% | $17.1M | 59 |
| JVA Coffee Holding Co., Inc. | $3.52 | +0.57% | $20.1M | 74 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $2.02 | +0.00% | $35.8M | 64 |
| BUBSF Bubs Australia Limited | $0.08 | +0.00% | $69.2M | 53 |
| LFVN LifeVantage Corporation | $6.58 | +1.31% | $83.1M | 77 |
| FTLF FitLife Brands, Inc. | $10.01 | -2.20% | $94.0M | 59 |
| HBFGF Happy Belly Food Group Inc. | $1.23 | +3.58% | $182M | 57 |
| USNA USANA Health Sciences, Inc. | $13.18 | -0.53% | $243M | 57 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are YGYIP's Key Strengths?
Diverse product portfolio across health, nutrition, and coffee segments.
- Established direct selling network for distribution.
- Proprietary coffee brands and blends.
- Vertical integration in hemp production for CBD oils.
What Are YGYIP's Weaknesses?
Negative profit margin indicating financial instability.
- High beta suggesting significant stock volatility.
- Reliance on OTC market for trading.
- Limited brand recognition compared to larger competitors.
What Could Drive YGYIP Stock Higher?
YGYIP catalyst: Potential regulatory changes in the CBD market could create new opportunities for the Commercial Hemp segment.
- Expansion of the direct selling network to new geographic regions.
- Strategic partnerships with wellness communities and cruise lines to increase coffee sales.
- Product innovation and diversification into new health and wellness categories.
- Increased online sales through e-commerce platforms and digital marketing.
What Are the Key Risks for YGYIP?
Financial-distress signal — its Altman Z-Score of -5.17 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Regulatory uncertainty in the CBD market could hinder growth and increase compliance costs.
- Intense competition from established players in the health and nutrition industry.
- Fluctuations in commodity prices for coffee and hemp could impact profitability.
- Dependence on the direct selling model, which is subject to changing consumer preferences and regulatory scrutiny.
- Negative profit margin and financial instability.
What Are the Growth Opportunities for YGYIP?
- Expansion of the Commercial Hemp Segment: The market for CBD products is projected to experience significant growth, driven by increasing consumer awareness and acceptance of CBD's potential health benefits. Youngevity's Commercial Hemp segment, which offers CBD oils, can capitalize on this trend by expanding its product line and distribution network.
- Growth in Direct Selling Network: Youngevity's direct selling segment offers a scalable distribution model, allowing the company to reach a broad customer base. By incentivizing distributors and expanding its product offerings, Youngevity can increase its sales volume and market penetration. The global direct selling market is estimated to be worth over $180 billion annually, providing a significant opportunity for Youngevity to expand its network and increase revenue.
- Strategic Partnerships in the Coffee Segment: Youngevity's Commercial Coffee segment can benefit from strategic partnerships with wellness and retirement communities, cruise lines, and coffee service operators. By offering customized coffee solutions and expanding its brand portfolio, Youngevity can increase its market share in the commercial coffee market. The global coffee market is projected to reach $175 billion by 2028, offering substantial growth potential for Youngevity's coffee segment.
- Product Innovation and Diversification: Youngevity can drive growth by continuously innovating its product offerings and diversifying into new categories within the health and wellness market. By identifying emerging consumer trends and developing innovative products, Youngevity can attract new customers and increase its revenue streams. The health and wellness market is constantly evolving, with new products and technologies emerging regularly, providing ample opportunities for Youngevity to innovate and grow.
- E-commerce Expansion and Digital Marketing: Youngevity can leverage its online platforms, such as youngevity.com and hempfx.com, to expand its e-commerce presence and reach a wider audience. By investing in digital marketing and optimizing its online sales channels, Youngevity can increase its online sales and brand awareness. The global e-commerce market is projected to continue growing rapidly, providing a significant opportunity for Youngevity to expand its online business and reach new customers.
What Are YGYIP's Competitive Advantages?
- Diverse product portfolio across multiple health and wellness categories.
- Established direct selling network.
- Proprietary coffee blends and brands.
- Vertically integrated hemp production and CBD oil extraction.
What Does YGYIP Do?
Founded in 1996 and headquartered in Chula Vista, California, Youngevity International, Inc. has evolved from AL International, Inc. (renamed in 2013) into a multi-faceted company focused on health and nutrition. The company operates through three segments: Direct Selling, Commercial Coffee, and Commercial Hemp. Its Direct Selling segment offers a wide array of products including nutritional supplements, weight management solutions, skincare, cosmetics, health and wellness products, packaged foods, lifestyle products, pet care items, digital products, telecare health services, apparel, fashion accessories, and business lending products. The Commercial Coffee segment produces and sells coffee under brands like Café La Rica and JavaFit, targeting both individual consumers and commercial clients such as wellness communities and cruise lines. The Commercial Hemp segment focuses on CBD oils derived from hemp. Youngevity distributes its products through its direct selling network and various consumer websites, including youngevity.com, heritagemakers.com, and hempfx.com. The company's strategy involves diversifying its product offerings and distribution channels to reach a broad customer base in the health and wellness market.
What Products and Services Does YGYIP Offer?
- Develops and distributes health and nutrition-related products.
- Operates through direct selling, commercial coffee, and commercial hemp segments.
- Offers nutritional supplements, weight management products, and skincare.
- Produces and sells coffee under various brands like Café La Rica and JavaFit.
- Markets CBD oils derived from hemp stock.
- Sells coffee and equipment to wellness communities and cruise lines.
- Distributes products through a network of distributors and online platforms.
How Does YGYIP Make Money?
- Direct sales through a network of independent distributors.
- Commercial sales of coffee and equipment to businesses.
- Online sales through company-owned websites.
- Revenue generation from nutritional supplements, health and wellness products, and CBD oils.
What Industry Does YGYIP Operate In?
Youngevity International, Inc. operates within the consumer defensive sector, specifically in the packaged foods and health & wellness segments. The industry is characterized by increasing consumer demand for health-conscious products and alternative wellness solutions. The competitive landscape includes established players in the nutritional supplement and coffee markets, as well as emerging companies in the CBD space.
Who Are YGYIP's Key Customers?
- Individual consumers seeking health and wellness products.
- Wellness and retirement communities.
- Cruise lines.
- Coffee service operators.
Company Profile
Youngevity International, Inc. operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Chula Vista, US. The company is led by CEO Stephan Wallach. YGYIP has traded publicly since 2019.
Key Financial Metrics
Return on assets is -58.0%, showing how much profit it generates from its asset base. A current ratio of 1.02 indicates the company holds enough short-term assets to cover its near-term obligations.
Financial Health
Youngevity International, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -5.17 places it in the distress zone, a signal of elevated financial risk.
YGYIP Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying could signal confidence in Youngevity's future prospects, suggesting those with inside knowledge believe the company is undervalued.
- Positive buzz in the social trading community indicates growing interest and potential for increased demand for Youngevity's products.
- The company's focus on health and wellness aligns with current consumer trends, potentially driving revenue growth and market share.
- Youngevity's direct selling model could provide resilience in a challenging economic climate, as individuals seek alternative income streams.
Bear Case
- Limited information available about Youngevity's financials raises concerns about transparency and potential risks.
- Negative sentiment expressed by some community members suggests dissatisfaction with the company's performance or products.
- Increased competition in the health and wellness sector could erode Youngevity's market position and profitability.
- Past controversies or regulatory issues associated with Youngevity may continue to weigh on investor sentiment and the company's reputation.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
YGYIP Latest News
No recent news available for YGYIP.
YGYIP Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for YGYIP.
Price Targets
Wall Street price target analysis for YGYIP.
YGYIP MoonshotScore
What does this score mean?
The MoonshotScore rates YGYIP 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Stephan Wallach
CEO
Stephan Wallach serves as the CEO of Youngevity International, Inc. His background includes extensive experience in management and operations. His leadership focuses on driving growth through strategic initiatives and operational efficiencies. He is responsible for overseeing the company's diverse business segments, including direct selling, commercial coffee, and commercial hemp. His expertise lies in navigating complex regulatory environments and fostering innovation within the organization.
Track Record: Under Stephan Wallach's leadership, Youngevity has focused on expanding its product portfolio and distribution channels. Key milestones include the growth of the Commercial Hemp segment and the development of strategic partnerships in the coffee segment. He has also emphasized improving operational efficiencies and streamlining the company's supply chain. However, profitability remains a challenge during his tenure.
YGYIP OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Youngevity International, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may be subject to less regulatory oversight than companies listed on major exchanges such as the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited liquidity and increased volatility. These companies may also have a higher risk of fraud or mismanagement.
- OTC Tier: OTC Other
- Limited liquidity due to low trading volume on the OTC market.
- Lack of regulatory oversight and transparency compared to major exchanges.
- Potential for wider bid-ask spreads and price volatility.
- Higher risk of fraud or mismanagement due to less stringent listing requirements.
- Difficulty in obtaining accurate and timely financial information.
- Verify the company's financial statements and audit reports.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal risks.
- Monitor the company's trading volume and price volatility.
- Consult with a financial advisor to assess the risks and potential rewards.
- Confirm the legitimacy of the company's operations and assets.
- Established history of operations since 1996.
- Diverse product portfolio across multiple segments.
- Multiple online platforms for direct-to-consumer sales.
- Presence in the direct selling industry with a network of distributors.
- Vertically integrated hemp production for CBD oils.
YGYIP Consumer Defensive Stock FAQ
What does Youngevity International, Inc. do?
Youngevity International, Inc. is a multi-channel company operating in the consumer defensive sector. It develops, manufactures, and distributes a wide range of health and nutrition-related products. These include nutritional supplements, gourmet coffee, weight management products, skincare and cosmetics, and CBD oils. The company operates through three segments: Direct Selling, Commercial Coffee, and Commercial Hemp.
What do analysts say about YGYIP stock?
As of March 16, 2026, formal analyst coverage of YGYIP is limited due to its OTC listing. Key valuation metrics such as P/E ratio are not meaningful due to negative earnings. The company's growth prospects are tied to the expansion of its CBD and coffee segments, but profitability remains a significant concern.
What are the main risks for YGYIP?
Youngevity International, Inc. faces several key risks. The company's negative profit margin of -35.3% indicates financial instability and challenges in achieving profitability. Its reliance on the OTC market exposes it to limited liquidity and regulatory oversight. The CBD market is subject to regulatory uncertainty, which could impact the Commercial Hemp segment.
What are the key factors to evaluate for YGYIP?
Evaluate YGYIP on fundamentals, analyst consensus, and risk factors. Youngevity International, Inc. presents a high-risk, high-reward investment profile. Not financial advice.
How frequently does YGYIP data refresh on this page?
YGYIP's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven YGYIP's recent stock price performance?
Youngevity International, Inc. (YGYIP) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio across health, nutrition, and coffee segments. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider YGYIP overvalued or undervalued right now?
Youngevity International, Inc. (YGYIP) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research YGYIP before investing?
Before investing in Youngevity International, Inc. (YGYIP), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited or delayed.